QNCX Prakiraan wutah bathi kanggo taun ngarep quincetx.com

Lambang korporat lan logo Quince (QNCX)

This chart on GURU.Markets shows moderate EPS growth prospects for the next fiscal year for Quince Therapeutics (QNCX), with the value holding at 0.00. This trend reflects the implementation of the AOC platform for treating rare metabolic pathologies. Stability is provided by the protection of drug delivery IT technologies and strict FDA control, as well as a patent shield in the field of targeted bone tissue therapy.

Quince (QNCX): Prakiraan wutah bathi resik saben saham ing taun ngarep saka 28.04.2023 nganti 12.10.2026

QNCX (Quince): rincian analitis lan laporan miturut indikator

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:QNCX, Quince Therapeutics Inc
Produk dadi Quince Therapeutics Inc

Long-term investing requires strict volatility control and an analysis of fundamental market expectations. For Quince Therapeutics (QNCX), this directly depends on the efficiency of temperature control during the transport of biomaterials, which impacts the success of clinical deliveries. The current trajectory of next year's EPS forecasts reflects the market consensus on profit dynamics, stripped of speculation, allowing for an assessment of the business's future profitability.

Analisis perusahaan pesaing

ASND (Ascendis) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Madrigal Pharmaceuticals|Prakiraan wutah bathi kanggo taun ngarep CORT|Prakiraan wutah bathi resik saben saham kanggo taun ngarep RYTM (Rhythm Pharma)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep akerotx.com AKRO|Metsera Therapeutics (MTSR) - Prakiraan wutah bathi resik saben saham ing taun ngarep|MLTX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|CRNX: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|NAMS: Prakiraan wutah bathi kanggo taun ngarep|SLNO - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Amicus Corp|89bio Pharma (ETNB) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep agios.com (AGIO)|Prakiraan wutah bathi saben saham kanggo taun ngarep structuretx.com GPCR|Prakiraan wutah bathi resik saben saham kanggo taun ngarep MiMedx Group Inc MDXG|Dinamika bathi saben saham sing diarepake ing taun ngarep RZLT|lexpharma.com - Prakiraan wutah bathi kanggo taun ngarep|MBX (MBX Biosciences Inc) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|ALT: Prakiraan wutah bathi kanggo taun ngarep|Aardvark Therapeutics Inc - Dinamika bathi saben saham sing diarepake ing taun ngarep|SGMT (Sagimet Biosciences, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep BioAge|Prakiraan wutah bathi kanggo taun ngarep BMEA|Proyeksi tambahing bathi saben saham ing taun ngarep GUTS|Prakiraan wutah bathi kanggo taun ngarep VTVT (vTv Therapeutics Inc.)|Dinamika bathi saben saham sing diarepake ing taun ngarep ATPC|Pluristem Therapeutics - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep synlogictx.com SYBX|LPCN: Prakiraan wutah bathi kanggo taun ngarep|Matinas BioPharma Holdings, Inc. - Dinamika bathi saben saham sing diarepake ing taun ngarep|SPRB (Spruce Biosciences Inc.) - Prakiraan wutah bathi kanggo taun ngarep|galecto.com (GLTO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Carmell Therapeutics (CTCX)|LUMO (Lumos Pharma Inc) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep organovo.com ONVO|Radius Health (RDUS) - Prakiraan wutah bathi resik saben saham ing taun ngarep